Fresh Hemp Foods Submits First Hemp Seed GRAS Notices To Satisfy FDA
Executive Summary
Canadian firm Fresh Hemp Foods submitted separate GRAS notices for hemp seed, protein and oil FDA Office of Food Additives. In each notice, firm says each hemp seed format is derived from varieties of cannabis sativa L. with low THC content, known as industrial hemp, that hemp seeds do not produce THC and that THC present in dehulled hemp seed comes from contact between the seeds and cannabinoid-containing resins from other plant parts during growth, harvest and processing.
You may also be interested in...
US Wellness Market In 2019: Farm Bill Made Cultivating Cannabidiol Policy FDA's Main Course In Supplements
As HBW Insight looks back on notable US wellness market developments and events for the previous 12 months, we find that news in the CBD space from the FDA and the industry dominated the sector throughout 2019.
House Appropriators Stoke Flames For FDA Regulation On CBD In Supplements
House Appropriations subcommittee with FDA oversight makes clear in questions for Commissioner Gottlieb they support allowing use of constituent ingredients from hemp and cannabis plants in food and dietary supplement products. Members also press for approving US firms' applications for pharmaceuticals with cannabis-derived active ingredients. Gottlieb announces working group will guide FDA decisions on potential CBD-use rulemaking.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.